Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, China23 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II Study of VB19055 in Uncontrolled or Resistant Hypertension | cardiovascular disorder, hypertensive disorder, resistant hypertension, vascular disorder | Not yet recruiting | Phase 2 | 2026-09-22 | NCT07833098 | |
| Predicting Efficacy of Preoperative Immunotherapy in Advanced Gastric Cancer | Advanced Gastric Cancer | Recruiting | Not stated | 2026-09-17 | NCT07824479 | |
| Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Characteristics of ACT500 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Complicated With Chronic Hepatitis B | Blood-Borne Infections, Chronic Disease, DNA Virus Infections, Digestive System Diseases, Disease Attributes, Hepadnaviridae infectious disease, Hepatitis, Chronic, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic hepatitis B virus infection, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, metabolic dysfunction-associated steatotic liver disease, viral hepatitis, viral infectious disease | Not yet recruiting | Phase 1 | 2026-09-14 | NCT07589400 | |
| Electroencephalographic Trajectories During Emergence From Inhalational and Total Intravenous Anesthesia | Emergence From Anesthesia | Not yet recruiting | Not stated | 2026-09-08 | NCT07806903 | |
| Clinical Applications of FAPI PET in Solid Tumors | Solid Tumor | Recruiting | Not applicable | 2026-08-20 | NCT07776899 | |
| Risk Factors and Outcomes in Coronary Chronic Total Occlusion | Arterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder | Recruiting | Not stated | 2026-08-18 | NCT06137521 | |
| The Efficacy and Safety of Inpegsomatropin Injection in Children With Turner Syndrome (TS) and Short Stature | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Sex Chromosome Disorders, Turner syndrome, Urogenital Abnormalities, Urogenital Diseases, cardiovascular disorder, chromosomal disorder, congenital heart disease, disorder of sexual differentiation, endocrine system disorder, gonadal disorder, gonadal dysgenesis, heart disorder, hereditary disease, sex chromosome disorder of sex development | Recruiting | Phase 3 | 2026-07-22 | NCT07614152 | |
| Dose-Ranging Study of LQ036 Single-Domain Antibody Nebulization Solution in Poorly Controlled Asthma | Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Phase 2 | 2026-06-25 | NCT07589439 | |
| Evaluate the Efficacy and Safety of Xianglei Tangzu Gao for the Treatment of Wagner Grade II Diabetic Foot Ulcers | Diabetes Complications, Diabetic Foot, Foot Ulcer, Leg Ulcer, Skin Ulcer, Skin and Connective Tissue Diseases, cardiovascular disorder, diabetes mellitus, diabetic neuropathy, diabetic peripheral angiopathy, endocrine system disorder, skin disorder, vascular disorder | Active, not recruiting | Phase 2 / Phase 3 | 2026-06-12 | NCT06531512 | |
| Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint (PADSTONE Study) | Acute-On-Chronic Liver Failure, Digestive System Diseases, Hepatic Insufficiency, acute liver failure, liver disorder, liver failure | Active, not recruiting | Not stated | 2026-05-26 | NCT05129904 | |
| Predictive Value of Gastrointestinal Blood Flow for Enteral Nutrition Intolerance in Critically Ill Patients | Critical Illness, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms | Recruiting | Not stated | 2026-04-09 | NCT07521111 | |
| Study of ABO2102 in KRAS-Mutated Solid Tumors | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Recruiting | Phase 1 | 2026-04-06 | NCT07455617 | |
| Standardized Implementation and Quality Assessment System for Confocal Enteroscopy | Confocal Enteroscopy; Quality Assessment System; Standardized Implementation | Recruiting | Not stated | 2026-01-23 | NCT07363291 | |
| AI System for Anatomic Recognition & Lesion Detection in Nasopharyngolaryngoscopy: A Prospective Study | Head and Neck Neoplasms, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, laryngeal disorder, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease, respiratory system disorder | Recruiting | Not stated | 2026-01-08 | NCT07326358 | |
| CAR-T Following ASCT for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (R/R B-NHL) With High-Risk Prognostic Factors | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2026-01-06 | NCT06365671 | |
| A Phase I Study of SIM0609 in Adult Participants With Locally Advanced/Metastatic Solid Tumors | Advanced Solid Cancer | Recruiting | Phase 1 | 2025-12-05 | NCT07265921 | |
| Peginterferon α-2b Injection for Hydroxyurea Resistant or Intolerant ET | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, blood coagulation disease, blood platelet disease, bone marrow disorder, essential thrombocythemia, hematologic disorder, hemorrhagic disease, thrombocytosis disease | Recruiting | Phase 2 | 2025-11-17 | NCT06552429 | |
| Relma-cel Followed by Tislelizumab for the Treatment of Relapsed/Refractory CNS Large B-Cell Lymphoma | primary central nervous system lymphoma | Recruiting | Phase 2 | 2025-03-14 | NCT06876688 | |
| A Multi-mode Thermophysical Immunotherapy Study for Breast Cancer Liver Metastases | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, liver disorder, neoplasm, skin disorder | Recruiting | Not applicable | 2025-03-14 | NCT06567353 | |
| Autologous Hematopoietic Stem Cell Boost Study After CAR-T Therapy | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2024-10-23 | NCT06589089 | |
| Zanubrutinib, Obinutuzumab and Lenalidomide (ZGR) in High-risk Treatment-naive Patients with Follicular Lymphoma (FL) | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Not yet recruiting | Phase 2 | 2024-10-15 | NCT06549335 | |
| A Study of LCAR-HL30 in Subjects With Relapsed/Refractory Hodgkin's Lymphoma and Anaplastic Large Cell Lymphoma | Hemic and Lymphatic Diseases, Hodgkins lymphoma, Neoplasms by Histologic Type, T-cell non-Hodgkin lymphoma, anaplastic large cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 | 2024-07-10 | NCT06494371 | |
| Real World Study of Linperlisib for Lymphoma Treatment | Focus on the Lymphoma Including B/T-cell Lymphoma | Not yet recruiting | Not stated | 2023-05-18 | NCT05863871 |